Platelets are versatile cells: from basic research to drug development
As part of our LMP Seminar Series we are delighted to welcome our speaker:
Dr. Heyu Ni, MD, PhD, FCAHS
Professor
LKSKI – Keenan Research Centre
Department of Laboratory Medicine & Pathobiology
University of Toronto
Talk title: "Platelets are versatile cells: from basic research to drug development"
Hosted by
How to join
The event will be in person, no need to register. Students and trainees must attend in person.
For faculty members who need to attend remotely, please register to receive the zoom link. Registration must be received by noon on Tuesday.
If you have any questions, please contact lmp.chairadmin@utoronto.ca for more details.
Wednesday, March 11, 2026
11 am - 12 pm
MSB 2170
Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON M5S 1A8
Details are sent to the LMP community in the Friday events bulletin.
Speaker bio: Dr. Heyu Ni, MD, PhD, FCAHS
Dr. Ni’s laboratory currently investigates the roles of adhesion molecules involved in hemostasis and thrombosis, inflammation/immune response, and tumorigenesis. His research team is currently studying the mechanisms of these processes using a confocal intravital microscopy suite, proteomics, and gene targeted mice. By directly monitoring molecular/cellular events in vivo, they hope to uncover some novel mechanisms of platelet aggregation, platelet-leukocyte/cancer cell interactions to enrich our knowledge in heart attack and stroke, inflammation and tumor metastasis. The laboratory also studies allo- and autoimmune diseases related to bleeding disorders such as Immune Thrombocytopenia (ITP), Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). They have established several novel murine models of ITP and FNAIT. His studies have been well funded by both internal and external grant agencies including Canadian Institutes of Health Research (CIHR) project and CIHR foundation, Heart and Stroke Foundation of Canada (HSFC), Canadian Blood Services (CBS), Canadian Foundation for Innovation (CFI), National Institutes of Health (NIH, USA), and NSFC-CIHR (China- Canada Joint Health Research Initiative Program). Dr. Ni has many high impact publications, acts as a reviewer for more than 40 scientific journals, sits on various scientific committees and granting agencies in Canada (HSFC, CIHR, NSFC-CIHR), China (NSFC), US (NIH), and Europe, and lectures at the local, national and international level.
